Medicine passport

TYSABRI 150 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Natalizumab
Strength
150 mg
Form
solución inyectable en jeringa precargada
ATC code
L04AG03
Registered in
Spain · Biogen Netherlands B.V.
Prescription
Prescription only
Nº Registro
106346002

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

France 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
TYSABRI150 mg · solution injectablePrescription onlyBIOGEN NETHERLANDS (PAYS-BAS)61863110

Source: Base de données publique des médicaments (ANSM / Ministère de la Santé) · 2026-09-30 · Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte.

Netherlands 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
Tysabri 150 mg oplossing voor injectie in een voorgevulde spuit150 mg · oplossing voor injectiePrescription onlyBiogen Netherlands B.V.EU/1/06/346

Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/es/en/medicines/tysabri-150-mg-solucion-inyectable-en-jeringa-precargada